{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:17:06Z","timestamp":1785377826646,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.medcli.2024.06.006","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T11:57:24Z","timestamp":1722513444000},"page":"449-457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of patient-reported outcomes measures (PROMs) and patient-reported experiences measures (PREMs) in Gaucher disease in Spain"],"prefix":"10.1016","volume":"163","author":[{"given":"Pilar","family":"Giraldo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Camprod\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma Cerro","family":"Alcolea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Gras-Colomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiana","family":"Ibarretxe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Lakhwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Purificaci\u00f3n Velasco","family":"Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Morales-Conejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2024.06.006_bib0135","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2024.06.006_bib0140","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.medcli.2024.06.006_bib0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/10245332.2016.1240391","article-title":"Gaucher disease epidemiology and natural history: a comprehensive review of the literature","volume":"22","author":"Nalysnyk","year":"2017","journal-title":"Hematology"},{"key":"10.1016\/j.medcli.2024.06.006_bib0150","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2004.08.015","article-title":"Gaucher disease: complexity in a \u201csimple\u201d disorder","volume":"83","author":"Sidransky","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.medcli.2024.06.006_bib0155","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/ajmg.a.61533","article-title":"Quality of life and psychological functioning of pediatric and young adult patients with Gaucher disease, type 1","volume":"182","author":"Alioto","year":"2020","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.medcli.2024.06.006_bib0160","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.medcli.2024.06.006_bib0165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/17446651.2018.1445524","article-title":"Recent advances in the diagnosis and management of Gaucher disease","volume":"13","author":"Gary","year":"2018","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.medcli.2024.06.006_bib0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ymgme.2020.12.291","article-title":"Gaucher disease: basic and translational science needs for more complete therapy and management","volume":"132","author":"Grabowski","year":"2021","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.medcli.2024.06.006_bib0175","first-page":"CD010324","article-title":"Enzyme replacement and substrate reduction therapy for Gaucher disease","author":"Shemesh","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.medcli.2024.06.006_bib0180","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.revmed.2018.11.012","article-title":"Gaucher disease: a review","volume":"40","author":"Nguyen","year":"2019","journal-title":"La Rev Med Intern"},{"key":"10.1016\/j.medcli.2024.06.006_bib0185","first-page":"61","article-title":"Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs)","volume":"6","author":"Weldring","year":"2013","journal-title":"Heal Serv Insights"},{"key":"10.1016\/j.medcli.2024.06.006_bib0190","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13023-023-02844-w","article-title":"Patient-reported outcomes in Gaucher's disease: a systematic review","volume":"18","author":"Feng","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.medcli.2024.06.006_bib0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13023-021-02163-y","article-title":"Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trials","volume":"17","author":"Elstein","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.medcli.2024.06.006_bib0200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bcmd.2015.10.001","article-title":"Patients with type 1 Gaucher disease in Spain: a cross-sectional evaluation of health status","volume":"56","author":"Giraldo","year":"2016","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.medcli.2024.06.006_bib0205","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0016-3287(69)80025-X","article-title":"An experimental study of group opinion: the Delphi method","volume":"1","author":"Dalkey","year":"1969","journal-title":"Futures"},{"key":"10.1016\/j.medcli.2024.06.006_bib0210","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1023\/A:1008878425167","article-title":"The impact of Gaucher disease and its treatment on quality of life","volume":"7","author":"Hayes","year":"1998","journal-title":"Qual Life Res"},{"key":"10.1016\/j.medcli.2024.06.006_bib0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13023-018-0810-x","article-title":"Patient reported outcome measures in rare diseases: a narrative review","volume":"13","author":"Slade","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.medcli.2024.06.006_bib0220","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/21642850.2018.1462705","article-title":"Health-related quality of life in children and adolescents living with Gaucher disease and their parents","volume":"6","author":"Remor","year":"2018","journal-title":"Heal Psychol Behav Med"},{"key":"10.1016\/j.medcli.2024.06.006_bib0225","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10545-006-0154-x","article-title":"Psychological complications of patients with Gaucher disease","volume":"29","author":"Packman","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.medcli.2024.06.006_bib0230","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ajh.20908","article-title":"Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention","volume":"82","author":"Mistry","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.medcli.2024.06.006_bib0235","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1182\/blood-2019-123000","article-title":"Not all patients with mild phenotype of Gaucher disease (GD) need disease specific treatment as reflected by patients reported outcomes measures","volume":"134","author":"Revel-Vilk","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2024.06.006_bib0240","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10897-017-0137-0","article-title":"Attitudes of individuals with Gaucher disease toward substrate reduction therapies","volume":"27","author":"Wagner","year":"2018","journal-title":"J Genet Couns"},{"key":"10.1016\/j.medcli.2024.06.006_bib0245","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1008814105603","article-title":"The health-related quality of life of adults with Gaucher's disease receiving enzyme replacement therapy: results from a retrospective study","volume":"7","author":"Damiano","year":"1998","journal-title":"Qual Life Res"},{"key":"10.1016\/j.medcli.2024.06.006_bib0250","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1023\/A:1008859420641","article-title":"Quality of life assessment in adults with type 1 Gaucher disease","volume":"8","author":"Masek","year":"1999","journal-title":"Qual Life Res"},{"key":"10.1016\/j.medcli.2024.06.006_bib0255","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1399-0004.2007.00811.x","article-title":"Imiglucerase (Cerezyme) improves quality of life in patients with skeletal manifestations of Gaucher disease","volume":"71","author":"Weinreb","year":"2007","journal-title":"Clin Genet"},{"key":"10.1016\/j.medcli.2024.06.006_bib0260","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/mgg3.339","article-title":"Improvement of life quality measured by Lansky Score after enzymatic replacement therapy in children with Gaucher disease type 1","volume":"6","author":"Cer\u00f3n-Rodr\u00edguez","year":"2018","journal-title":"Mol Genet Genomic Med"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324004524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324004524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T15:00:51Z","timestamp":1730991651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775324004524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0025775324004524"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2024.06.006","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of patient-reported outcomes measures (PROMs) and patient-reported experiences measures (PREMs) in Gaucher disease in Spain","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2024.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}